SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-115937
Filing Date
2022-11-08
Accepted
2022-11-08 16:12:59
Documents
14
Period of Report
2022-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2230063d1_8k.htm   iXBRL 8-K 27048
2 EXHIBIT 99.1 tm2230063d1_ex99-1.htm EX-99.1 80516
6 GRAPHIC image_001.jpg GRAPHIC 3315
  Complete submission text file 0001104659-22-115937.txt   296358

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nvax-20221108.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20221108_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20221108_pre.xml EX-101.PRE 22593
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2230063d1_8k_htm.xml XML 3479
Mailing Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 221369036
SIC: 2836 Biological Products, (No Diagnostic Substances)